Warning: mysql_query() expects parameter 2 to be resource, object given in /home/abundancethebook/abundancethebook.com/wp-content/plugins/wordpress-form-manager/db.php on line 35

Warning: mysql_num_rows() expects parameter 1 to be resource, null given in /home/abundancethebook/abundancethebook.com/wp-content/plugins/wordpress-form-manager/db.php on line 745
Vaccine Manufacturing Gets Boost from Tobacco Plants

A New York Times and Amazon.com bestseller – Buy now

Vaccine Manufacturing Gets Boost from Tobacco Plants

Canada-Based Medicago Opens U.S. Facility to Exploit Its Influenza Vaccine Production Method…

Medicago says it’s improving the production of influenza vaccines in two ways: The firm starts with virus-like particles (VLPs) to generate a vaccine, and then it manufactures large quantities of a vaccine in the leaves of tobacco plants. Its technology platform is readily adaptable for the mass production of seasonal and pandemic vaccines, as well as biosimilars and other types of proteins.

Medicago’s manufacturing platform uses Nicotiana benthamiana, also known as Australian tobacco. In 1999, Louis-Phillippe Vezina, Ph.D., co-founded Medicago to explore the manufacturing of proteins in alfalfa plants. Dr. Vezina, CSO, named the company Medicago after the Latin name for alfalfa. Company researchers later discovered that tobacco produces higher yields of VLP-based vaccines than alfalfa.

From Genetic Engineering & Biotechnology News

© Copyright 2012 Abundance the Book - by Peter Diamandis and Steven Kotler. All Rights Reserved. - Read Our Privacy Policy